Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients

BACKGROUND: To retrospectively evaluate the efficacy and toxicity of definitive concurrent chemoradiotherapy (dCRT) with cisplatinum/paclitaxel versus cisplatinum/5-fluorouracil in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who received nonsurgical treatment. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Guofang, Wang, Zhehai, Wang, Yuan, Zhang, Qingqing, Tang, Ning, Guo, Jun, Liu, Liyan, Han, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936807/
https://www.ncbi.nlm.nih.gov/pubmed/27445460
http://dx.doi.org/10.2147/DDDT.S105441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936807/
https://www.ncbi.nlm.nih.gov/pubmed/27445460
http://dx.doi.org/10.2147/DDDT.S105441

Ejemplares similares